References
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA), 2019. Available from: http://www.ginasthma.org/ [last accessed 23 May 2020].
- Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, Cantón R, Vendrell M, Polverino E, de Gracia J, et al. Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults. Arch Bronconeumol 2018;54(2):79–87. doi:https://doi.org/10.1016/j.arbr.2017.07.013.
- Kang HR, Choi G-S, Park SJ, Song YK, Kim JM, Ha J, Lee YH, Lee BH, Kim S-H, Lee JH, et al. The effects of bronchiectasis on asthma exacerbation. Tuberc Respir Dis (Seoul) 2014;77(5):209–214. doi:https://doi.org/10.4046/trd.2014.77.5.209.
- Lynch DA, Newell JD, Tschomper BA, Cink TM, Newman LS, Bethel R. Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 1993;188(3):829–833. doi:https://doi.org/10.1148/radiology.188.3.8351357.
- Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Methods of systematic reviews and meta-analysis preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6(7):e1000097. doi:https://doi.org/10.1371/journal.pmed.1000097.
- Rostom A, Dube C, Cranney A. Celiac disease. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Sep. (Evidence Reports/Technology Assessments, No 104.) Appendix D. Quality Assessment Forms. Available from: http://www.ncbi.nlm.nih.gov/books/NBK35156 [last accessed 23 May 2020].
- Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004;23(9):1351–1375. doi:https://doi.org/10.1002/sim.1761.
- Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5(1):13. doi:https://doi.org/10.1186/1471-2288-5-13.
- Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). Cochrane; 2019. Available from www.training.cochrane.org/handbook [last accessed 23 May 2020].
- Padilla-Galo A, Olveira C, Fernández de Rota-Garcia L, Marco-Galve I, Plata AJ, Alvarez A, Rivas-Ruiz F, Carmona-Olveira A, Cebrian-Gallardo JJ, Martinez-Garcia MA, et al. Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients. Respir Res 2018;19(1):43. doi:https://doi.org/10.1186/s12931-018-0746-7.
- Oguzulgen IK, Kervan F, Ozis T, Turktas H. The impact of bronchiectasis in clinical presentation of asthma. South Med J 2007;100(5):468–471. doi:https://doi.org/10.1097/SMJ.0b013e31802fa16f.
- Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy 2011;66(5):679–685. doi:https://doi.org/10.1111/j.1398-9995.2010.02542.x.
- Coman I, Pola-Bibián B, Barranco P, Vila-Nadal G, Dominguez-Ortega J, Romero D, Villasante C, Quirce S. Bronchiectasis in severe asthma: clinical features and outcomes. Ann Allergy Asthma Immunol 2018;120(4):409–413. doi:https://doi.org/10.1016/j.anai.2018.02.016.
- García-Clemente M, Enríquez-Rodríguez AI, Iscar-Urrutia M, Escobar-Mallada B, Arias-Guillén M, López-González FJ, Madrid-Carbajal C, Pérez-Martínez L, Gonzalez-Budiño T. Severe asthma and bronchiectasis. J Asthma 2020;57(5):505–509. doi:https://doi.org/10.1080/02770903.2019.1579832.
- Alyasin S, Moghtaderi M, Farjadian S, Babaei M, Teshnizi SH. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis. Elect Phys 2018;10(1):6273–6278. doi:https://doi.org/10.19082/6273.
- Mao B, Yang JW, Lu HW, Xu JF. Asthma and bronchiectasis exacerbation. Eur Respir J 2016;47(6):1680–1686. doi:https://doi.org/10.1183/13993003.01862-2015.
- Bisaccioni C, Aun MV, Cajuela E, Kalil J, Agondi RC, Giavina-Bianchi P. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis. Clinics (Sao Paulo) 2009;64(8):769–773. doi:https://doi.org/10.1590/S1807-59322009000800010.
- Boyton RJ, Smith J, Ward R, Jones M, Ozerovitch L, Wilson R, Rose M, Trowsdale J, Altmann DM. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med 2006;173(3):327–333. doi:https://doi.org/10.1164/rccm.200501-124OC.
- Boyton RJ, Smith J, Jones M, Reynolds C, Ozerovitch L, Chaudhry A, Wilson R, Rose M, Altmann DM. Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clin Exp Immunol 2008;152(1):95–101. doi:https://doi.org/10.1111/j.1365-2249.2008.03596.x.
- Lo D, Maniyar A, Gupta S, Gaillard E. High prevalence of bronchiectasis on chest CT in a selected cohort of children with severe Asthma. BMC Pulm Med 2019;19(1):136. doi:https://doi.org/10.1186/s12890-019-0900-0.
- Lujan M, Gallardo X, Amengual MJ, Bosque M, Mirapeix RM, Domingo C. Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels. Biomed Res Int 2013;2013:1–7. doi:https://doi.org/10.1155/2013/109219.
- Harmanci E, Kebapci M, Metintas M, Ozkan R. High-resolution computed tomography findings are correlated with disease severity in asthma. Respiration 2002;69(5):420–426. doi:https://doi.org/10.1159/000064018.
- Kim S, Lee CH, Jin KN, Cho SH, Kang HR. Severe asthma phenotypes classified by site of airway involvement and remodeling via chest CT scan. J Invest Allergol Clin Immunol 2018;28(5):312–320. doi:https://doi.org/10.18176/jiaci.0265.
- Dimakou K, Gousiou A, Toumbis M, Kaponi M, Chrysikos S, Thanos L, Triantafillidou C. Investigation of bronchiectasis in severe uncontrolled asthma. Clin Respir J 2018;12(3):1212–1218. doi:https://doi.org/10.1111/crj.12653.
- Watson SH, Kibler CS. The role of allergy in bronchiectasis. J Allergy 1939;10(4):364–376. doi:https://doi.org/10.1016/S0021-8707(39)90151-6.
- Varpela E, Laitinen LA, Keskinen H, Korhola O. Asthma, allergy and bronchial hyper-reactivity to histamine in patients with bronchiectasis. Clin Allergy 1978;8(3):273–280. doi:https://doi.org/10.1111/j.1365-2222.1978.tb03224.x.
- Pang J, Chan HS, Sung JY. Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study. Thorax 1989;44(11):948–951. doi:https://doi.org/10.1136/thx.44.11.948.
- Ip M, Lam W, So S, Liong E, Chan C, Tse K. Analysis of factors associated with bronchial hyperreactivity to methacholine in bronchiectasis. Lung 1991;169(1):245. doi:https://doi.org/10.1007/BF02714159.
- Pang J, Chan HS, Sung JY. Prevalence of asthma in patients with bronchiectasis in Hong Kong. Eur Respir J 1993;6(1):148–149.
- Säynäjäkangas O, Keistinen T, Tuuponen T, Kivelä SL. Links between hospital diagnoses of bronchiectasis and asthma. Allergy 1997;52(11):1120–1122. doi:https://doi.org/10.1111/j.1398-9995.1997.tb00186.x.
- Holmgren A, Ripe E. Airway conductance after inhalation of microaerosols of histamine chloride in healthy subjects and in patients with bronchiectasis before and after operation. Scand J Respir Dis. 1973;54(4):215–222.
- Bahous J, Cartier A, Pineau L, Bernard C, Ghezzo H, Martin RR, Malo JL. Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult. Bull Eur Physiopathol Respir 1984;20(4):375–380.
- Olveira C, Padilla A, Martínez-García M-Á, de la Rosa D, Girón R-M, Vendrell M, Máiz L, Borderías L, Polverino E, Martínez-Moragón E, et al. Etiology of bronchiectasis in a cohort of 2047 patients. An analysis of the Spanish Historical Bronchiectasis Registry. Arch Bronconeumol 2017;53(7):366–374. doi:https://doi.org/10.1016/j.arbr.2017.05.005.
- Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, Polverino E, Van de Kerkhove C, Rutherford R, Davison J, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc 2015;12(12):1764–1770. doi:https://doi.org/10.1513/AnnalsATS.201507-472OC.
- Cole PJ. Inflammation: a two-edged sword – the model of bronchiectasis. Eur J Respir Dis Suppl 1986;147:6–15.
- Scheinberg P, Shore E. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 2005;127(4):1420–1426. doi:https://doi.org/10.1016/S0012-3692(15)34496-2.
- Murray MP, Govan JRW, Doherty CJ, Simpson AJ, Wilkinson TS, Chalmers JD, Greening AP, Haslett C, Hill AT. A randomized controlled trial of nebulized gentamicin in non–cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2011;183(4):491–499. doi:https://doi.org/10.1164/rccm.201005-0756OC.
- Athanazio R. Airway disease: similarities and differences between asthma, COPD and bronchiectasis. Clinics (Sao Paulo) 2012;67(11):1335–1343. doi:https://doi.org/10.6061/clinics/2012(11)19.